COVID-19 outbreak impact on urolithiasis treatments: A multicenter retrospective study across 9 urological centers in Italy
Giorgio Mazzon , Stefania Ferretti , Emanuele Serafin , Francesco Claps , Pietro Acquati , Davide Brusa , Federico Germinale , Giuseppe Celentano , Andrea Pescuma , Andrea Vismara Fugini , Davide Campobasso , Umberto Maestroni , Giovanni Costa , Tonino Morena , Flavia DiMarco , Andrea Baudo , Massimiliano Creta , Nicola Pavan , Marco Ticonosco , Angelo Peroni , Devis Collura , Maria Angela Cerruto , Alessandro Antonelli , Luca Carmignani , Salvatore Micali , Carlo Trombetta , Giovanni Muto , Antonio Celia
Current Urology ›› 2024, Vol. 18 ›› Issue (4) : 301 -306.
Background: The coronavirus disease (COVID-19) pandemic has posed challenges to the global health care community, affecting the management of upper urinary tract stones.
Materials and methods: This retrospective study involved 9 Italian centers. We compared the 12-month period prior to COVID-19 (March 1, 2019, to February 28, 2020; Period A) with the COVID-19 period (March 1, 2020, to February 28, 2021, Period B). This study aimed to compare outcomes during Periods A and B, specifically focusing on the overall number of treatments, rate of urgent/elective cases, and operational complexity.
Results: A total of 4018 procedures were collected, comprising 2176 procedures during Period A and 1842 during Period B, indicating a loss of 15.35% (p < 0.001). In the elective cases, 1622 procedures were conducted in Period A, compared with 1280 in Period B, representing a 21.09% reduction in cases (p = 0.001). All types of stone treatments were affected: extracorporeal shock wave lithotripsy (−29.37%, p = 0.001), percutaneous nephrolithotomy (−26.47%, p = 0.008), retrograde surgeries for renal stones (−10.63%, p = 0.008), and semirigid ureterolithotripsy (−24.86%, p = 0.008). Waiting lists experienced significant delays during Period B. The waiting time (WT) for elective procedures increased during Period B (p < 0.001). For ureteral stones, the mean WT in Period A was 61.44 days compared with 86.56 days in Period B (p = 0.008). The WT for renal stones increased from 64.96 days in Period A to 85.66 days in Period B for retrograde intrarenal surgery (p = 0.008) and from 96.9 days to 1103.9 days (p = 0.035) for percutaneous nephrolithotomy procedures.
Conclusions: Our study demonstrates that COVID-19 significantly disrupted endourological services across the country. Our data underline how patients received treatment over a prolonged period, potentially increasing the risk of stone-related complications and patient discomfort.
COVID-19 / Urolithiasis / Percutaneous nephrolithotomy / Retrograde intrarenal surgery / Extracorporeal shock wave lithotripsy
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
Ministero della Salute, ipartimento della Protezione Civile. DCOVID-19 situazione Italia 2021. Available at: https://opendatadpc.maps.arcgis.com/apps/dashboards/b0c68bce2cce478eaac82fe38d4138b1. Accessed August 8, 2022. |
| [5] |
World Health Organization (WHO). Weekly epidemiological update on COVID-19—3 August 2022. Available at: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---3-August-2022. Accessed August 9, 2022. |
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
World Health Organization. Coronavirus. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed July 31, 2022. |
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
/
| 〈 |
|
〉 |